Characterization of central- and peripheral-type benzodiazepine receptors in rat salivary glands

Biochemical Pharmacology
H Yamagishi, M Kawaguchi

Abstract

Benzodiazepines have been shown to inhibit salivary secretion from the rat salivary gland. This action is mediated by specific benzodiazepine binding sites in the glands. The presence and characteristics of central- and peripheral-type benzodiazepine receptors in rat parotid and submandibular glands were examined employing [3H]Ro15-1788 and [3H]PK11195 as radioligands. [3H]Ro15-1788 and [3H]PK11195 bound with high affinity for both salivary glands ([3H]Ro15-1788: 24.5 and 37.4 mM, [3H]PK11195: 1.37 and 1.88 nM, for parotid and submandibular glands, respectively). [3H]Ro15-1788 binding sites occupied only 0.22 to 0.43% of the total binding for benzodiazepine receptors in the glands. The rank order of the competing potency of [3H]Ro15-1788 binding (Ro15-1788 = clonazepam > diazepam > flunitrazepam > PK11195 > Ro5-4864) and [3H]PK11195 binding (Ro5-4864 = PK11195 > diazepam = flunitrazepam > clonazepam) demonstrated that [3H]Ro15-1788 and [3H]PK11195 binding sites were characteristic of the central and peripheral type, respectively. These studies show that both central- and peripheral-type benzodiazepine receptors exist in rat parotid and submandibular glands.

References

Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·C Braestrup, R F Squires
Jan 1, 1992·Journal of Neurochemistry·E EscubedoJ Camarasa
Feb 1, 1992·Trends in Pharmacological Sciences·A Doble, I L Martin
Jan 1, 1992·Clinical Neuropharmacology·W Sieghart
Dec 1, 1992·Trends in Pharmacological Sciences·W Sieghart
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·Y KataokaE Costa
Feb 28, 1994·Neuroscience Letters·M ParramónF A Stephenson

❮ Previous
Next ❯

Citations

Dec 1, 1998·European Journal of Pharmacology·M Okubo, M Kawaguchi
Feb 5, 2011·European Journal of Pharmacology·Kazunori OuchiMitsuru Kawaguchi
Mar 19, 2009·European Journal of Pharmacology·Yasuhiro KosugeTakayuki Sakai
Feb 9, 2000·Toxicology and Applied Pharmacology·P J ForshawD E Ray
Dec 6, 2005·Pharmacology & Therapeutics·David E Ray, Jeffrey R Fry
Mar 21, 2019·Community Dentistry and Oral Epidemiology·Jamie Raffaele IanunzioMarco Aurelio Peres
Jan 1, 2006·Toxicology Mechanisms and Methods·Abdollah Osman AhmedMohammad Abdollahi
Jan 17, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·M A OstuniJ-J Lacapere
Aug 2, 2006·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Mitsuru KawaguchiYasuhiro Kosuge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.